Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Convective Radiofrequency Water Vapor Thermal Ablation (REZUM) Versus Tamsulosin in Management of Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement

NCT07169773 is registered in ClinicalTrials.gov with khaled Abdelsattar Gad Ibrahim as lead sponsor.

NCT NCT07169773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07169773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Convective Radiofrequency Water Vapor Thermal Ablation (REZUM) Versus Tamsulosin in Management of Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement
Lead sponsor
khaled Abdelsattar Gad Ibrahim
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
June 1, 2023
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate hyperplasia